Dysregulated Expression of Transcription Factor PU. 1 (Sfpi1) in Pre-B-Cell Acute Lymphoblastic Leukemia/Lymphoma Is Associated with Aggressive Clinical Course

被引：0
|
作者：
Mirza, I.
Surmawala, A.
Szkotak, A.
Torlakovic, E.
Mansoor, A.
机构：
[1] Univ Alberta, Edmonton, AB, Canada
[2] Univ Saskatchewan, Saskatoon, SK, Canada
[3] Univ Calgary, Calgary Lab Serv, Calgary, AB, Canada
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1394
引用
收藏
页码：312A / 312A
页数：1
相关论文
共 50 条
  • [31] Expression level of pre-B-cell leukemia transcription factor 2 (PBX2) as a prognostic marker for gingival squamous cell carcinoma
    Satoru TOYOSAWA
    Katsuyuki AOZASA
    Eiichi MORII
    Journal of Zhejiang University-Science B(Biomedicine & Biotechnology), 2012, (03) : 168 - 175
  • [32] Expression level of pre-B-cell leukemia transcription factor 2 (PBX2) as a prognostic marker for gingival squamous cell carcinoma
    Satoru TOYOSAWA
    Katsuyuki AOZASA
    Eiichi MORII
    Journal of Zhejiang University-Science B(Biomedicine & Biotechnology), 2012, 13 (03) : 168 - 175
  • [33] Expression level of pre-B-cell leukemia transcription factor 2 (PBX2) as a prognostic marker for gingival squamous cell carcinoma
    Qiu, Ying
    Wang, Zhu-ling
    Jin, Shu-qing
    Pu, Yu-fei
    Toyosawa, Satoru
    Aozasa, Katsuyuki
    Morii, Eiichi
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2012, 13 (03): : 168 - 175
  • [34] Dysregulation of metallothionein MT1 sub-types in TCF3::PBX1 :: PBX1 pre-B-cell acute lymphoblastic leukemia
    Agnihotri, Aditi
    Kamble, Vinesh S.
    Khare, Satyajeet P.
    CANCER GENETICS, 2024, 288 : 54 - 58
  • [35] p16 inactivation associated with aggressive clinical course and fatal outcome in TEL/AML1-positive acute lymphoblastic leukemia
    Papadhimitriou, SI
    Polychronopoulou, S
    Tsakiridou, AA
    Androutsos, G
    Paterakis, GS
    Athanassiadou, E
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2005, 27 (12) : 675 - 677
  • [36] Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line
    Tufekci, Ozlem
    Yandim, Melis Kartal
    Oren, Hale
    Irken, Gulersu
    Baran, Yusuf
    LEUKEMIA RESEARCH, 2015, 39 (03) : 342 - 347
  • [37] IDENTIFICATIONS OF NOVEL RECURRENT PU.1 FUSIONS WITH HIGHLY AGGRESSIVE PHENOTYPE IN PEDIATRIC T CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Seki, M.
    Kimura, S.
    Isobe, T.
    Yoshida, K.
    Ueno, H.
    Suzuki, H.
    Shiozawa, Y.
    Kataoka, K.
    Fujii, Y.
    Shiraishi, Y.
    Chiba, K.
    Tanaka, H.
    Shimamura, T.
    Lin, L.
    Takagi, M.
    Wang, C.
    Iwama, A.
    Ohki, K.
    Kato, M.
    Arakawa, Y.
    Koh, K.
    Hanada, R.
    Moritake, H.
    Akiyama, M.
    Kobayashi, R.
    Deguchi, T.
    Hashii, Y.
    Imamura, T.
    Sato, A.
    Kiyokawa, N.
    Oka, A.
    Hayashi, Y.
    Manabe, A.
    Ohara, A.
    Horibe, K.
    Sanada, M.
    Mano, H.
    Miyano, S.
    Ogawa, S.
    Takita, J.
    HAEMATOLOGICA, 2017, 102 : 327 - 328
  • [38] Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia (vol 94, pg 1918, 2006)
    Mueller, B. U.
    Pabst, T.
    Hauser, P.
    Neuberg, D.
    Tenen, D. G.
    BRITISH JOURNAL OF CANCER, 2006, 95 (04) : 554 - 554
  • [39] TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia
    Sanda, Takaomi
    Leong, Wei Zhong
    EXPERIMENTAL HEMATOLOGY, 2017, 53 : 7 - 15
  • [40] CKLF and IL1B transcript levels at diagnosis are predictive of relapse in children with pre-B-cell acute lymphoblastic leukaemia
    Fitter, Stephen
    Bradey, Alanah L.
    Kok, Chung Hoow
    Noll, Jacqueline E.
    Wilczek, Vicki J.
    Venn, Nicola C.
    Law, Tamara
    Paisitkriangkrai, Sakrapee
    Story, Colin
    Saunders, Lynda
    Dalla Pozza, Luciano
    Marshall, Glenn M.
    White, Deborah L.
    Sutton, Rosemary
    Zannettino, Andrew C. W.
    Revesz, Tamas
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (01) : 171 - 175
12345